KTTAW 8-K 2026-09-16

Pasithea Therapeutics Corp. (KTTAW) 8-K dated 2026-09-16 — accession 0001213900-26-100515. This URL is the filing, not the KTTAW hub.

Pasithea Therapeutics Corp. (KTTAW) is a biotechnology company listed on US.

Pasithea Therapeutics Corp. filed a 8-K on 2026-09-16. Accession 0001213900-26-100515.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported KTTAW revenue for 2022-12-31 was $486.6K. Net income was -$13.9M. Revenue was up 3130.4% from 2021-12-31 to 2022-12-31. KTTAW currently screens at market cap $100.2K.

Not investment advice. The KTTAW SEC hub lists recent forms. The stock page is the research view.